Form 8-K - Current report:
SEC Accession No. 0001490978-23-000055
Filing Date
2023-05-24
Accepted
2023-05-24 16:37:15
Documents
19
Period of Report
2023-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-20230524.htm   iXBRL 8-K 43311
2 EX-1.1 schrodingeratm-exx11salesa.htm EX-1.1 298675
3 EX-5.1 sdgr-20230524xexx51opinion.htm EX-5.1 13512
4 EX-23.1 sdgr-20230524xexx231whcons.htm EX-23.1 13522
8 wilmerlocationsfooter.jpg GRAPHIC 131420
9 wilmerlocationsfooterb.jpg GRAPHIC 131420
10 wilmerlogo.jpg GRAPHIC 19690
11 wilmerlogob.jpg GRAPHIC 19690
  Complete submission text file 0001490978-23-000055.txt   1001918

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20230524.xsd EX-101.SCH 1911
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20230524_lab.xml EX-101.LAB 25850
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20230524_pre.xml EX-101.PRE 13587
13 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20230524_htm.xml XML 13548
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 23954654
SIC: 2834 Pharmaceutical Preparations